Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.62 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.62 |
| ▸ | MMP2 | P08253 | 1/20 | 0.58 |
| ▸ | GNPAT | O15228 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | ECE1 | P42892 | 1/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.51 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120877 | 1.00 | ERAP2 (0.62) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL30051985 | 0.97 | GNPAT (0.62) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL30915103 | 0.97 | GNPAT (0.62) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL170652 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL29382413 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL9747671 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL29372662 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL28540087 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL1711485 | 0.97 | ERAP2 (0.65) | ERAP2LNPEPMMP2GNPATOPRK1 | |
| SCHEMBL29883922 | 0.96 | ERAP2 (0.59) | ERAP2LNPEPMMP2GNPATOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |